0001104659-24-034035.txt : 20240313
0001104659-24-034035.hdr.sgml : 20240313
20240313181023
ACCESSION NUMBER: 0001104659-24-034035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBERTSON MICHELLE
CENTRAL INDEX KEY: 0001755098
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 24747286
MAIL ADDRESS:
STREET 1: C/O MOMENTA PHARMACEUTICALS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm248737-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-11
0
0001526119
Verastem, Inc.
VSTM
0001755098
ROBERTSON MICHELLE
C/O VERASTEM, INC., 117 KENDRICK ST.,
SUITE 500
NEEDHAM
MA
02494
1
0
0
0
0
Stock Option (right to buy)
37.32
2024-03-11
4
D
0
5291
D
2031-11-15
Common Stock
5291
0
D
Stock Option (right to buy)
11.44
2024-03-11
4
A
0
5291
A
2034-03-11
Common Stock
5291
5291
D
On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.
The canceled stock option was granted on November 15, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from November 2021 to October 2022.
/s/ Daniel Calkins, Attorney in Fact
2024-03-13